Dr. Rosner obtained his M.D. from Ben-Gurion University (Israel), followed by obtaining his specialty in Dermatology and Venereology from the Ha'emek Medical Center (Israel) in 1996. In 2001, he graduated with a Ph.D. in Immunology and Molecular Biology from the University of Copenhagen (Denmark). Dr. Rosner conducted postdoctoral research in the laboratory of Dr. Vilhelm Bohr at the National Institute of Aging (United States). Since 2006, Dr. Rosner has been Principal Investigator and Director of Dermatology Research at Wayne State University (United States). Over the last decade, Dr. Rosner’s research has focused on the development of genetic-based melanoma therapy, as well as the identification of novel melanoma biomarkers. In 2011, Dr. Rosner published a new anti-cancer therapeutic platform, which he pioneered and developed to treat melanoma and other cancer types by utilizing a novel form of suicide gene therapy. His therapeutic platform is comprised of a series of genetic constructs that have initially demonstrated 70-100% killing efficiency in melanoma cells. Recently, Dr. Rosner has extended the repertoire of his genetic constructs and has further elucidated their anti-cancer properties.


Samir A. Farghaly, Professor Samir A. Farghaly, The Weill Medical College Of Cornell University, USA, Doctor Samir A. Farghaly, Samir A. Farghaly biography, scientific conferences, Cancer Science-2013 conference

Speaker Presentations

Speaker PDFs